Li Yuanzhen, Li Lianglan, Lin Hong, Li Wei, Wan Jinglin, Hao Haibin, Tong Zhihui, Li Weiqin
Clin Lab. 2025 Mar 1;71(3). doi: 10.7754/Clin.Lab.2024.241028.
Cold atmospheric plasma (CAP) has shown good clinical efficacy in treating chronic wounds, but its superiority over conventional treatment is still under debate. This meta-analysis systematically analyzed the clinical efficacy of CAP compared to control therapy.
Relevant literature was obtained online according to PRISMA guidelines. Randomized controlled trials (RCTs) were selected based on reduced bacterial load and wound size or area in chronic wounds as observation outcomes. The data were pooled and analyzed using REVMAN 5.2.
Twelve studies were included in the meta-analysis, comprising two on wound bacterial load, four on wound size or area, and six on both wound bacterial load and size. For the reduction in wound size or area, CAP showed a significant superior effect compared to the control group. Out of the five RCTs that evaluated wound size, CAP showed a higher number of wounds reduced (CAP vs. control: OR = 1.75; 95% CI = 1.11 - 2.77; p = 0.02). The percentage of relative reduced wound area was evaluated by five RCTs (CAP vs. control: MD = 43.24%; 95% CI = 24.95% - 61.54%; p < 0.00001). For reduced bacterial load, CAP also showed significantly better efficacy than control, as evaluated in eight RCTs (CAP vs. control: OR = 2.06; 95% CI = 1.16 - 3.68; p = 0.01).
A total of 448 patients with chronic wounds were included in all 12 meta-analysis studies, indicating that CAP has better clinical efficacy in treating chronic wounds. These findings provide a valuable reference for the clinical application of CAP.
冷大气等离子体(CAP)在治疗慢性伤口方面已显示出良好的临床疗效,但其相对于传统治疗的优越性仍存在争议。本荟萃分析系统地分析了CAP与对照治疗相比的临床疗效。
根据PRISMA指南在线获取相关文献。以慢性伤口中细菌负荷降低以及伤口大小或面积作为观察结果,选择随机对照试验(RCT)。使用REVMAN 5.2对数据进行汇总和分析。
荟萃分析纳入了12项研究,其中两项关于伤口细菌负荷,四项关于伤口大小或面积,六项关于伤口细菌负荷和大小两者。对于伤口大小或面积的减小,与对照组相比,CAP显示出显著的优越效果。在评估伤口大小的五项RCT中,CAP显示伤口减小的数量更多(CAP与对照组相比:OR = 1.75;95%CI = 1.11 - 2.77;p = 0.02)。五项RCT评估了相对伤口面积减小的百分比(CAP与对照组相比:MD = 43.24%;95%CI = 24.95% - 61.54%;p < 0.00001)。对于细菌负荷降低,在八项RCT中评估显示,CAP的疗效也显著优于对照组(CAP与对照组相比:OR = 2.06;95%CI = 1.16 - 3.68;p = 0.01)。
所有12项荟萃分析研究共纳入448例慢性伤口患者,表明CAP在治疗慢性伤口方面具有更好的临床疗效。这些发现为CAP的临床应用提供了有价值的参考。